Who’s Doing What On EMA Call For GVK Suspensions
This article was originally published in PharmAsia News
Executive Summary
The European Commission says that "within roughly a month" it will make its decision on the European Medicines Agency's recommendation that hundreds of formulations and strengths of generic medicines whose European marketing authorizations relied on clinical studies performed by Indian contract research organization GVK Biosciences be suspended in the EU.